Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zevalin Post-marketing Surveillance in Japan (ZEVALIN-DUI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by Spectrum Pharmaceuticals, Inc
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc Identifier:
First received: August 17, 2011
Last updated: October 30, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)